Royal Marsden NHS Foundation Trust: Lung Neoplasms trials

The registry lists 10 Lung Neoplasms studies with Royal Marsden NHS Foundation Trust as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung CancerRecruitingNCT07008742
• Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis StudyRecruitingNCT05432739
• Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid BiopsiesCompletedNCT04566614
• Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer TreatmentStatus unknownNCT04440800
• Lung Nodule Imaging Biobank for Radiomics and AI ResearchStatus unknownNCT04270799
• Phase I Trial of VS-6766 Alone and in Combination With EverolimusCompletedNCT02407509Phase 1
• Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified TumoursStatus unknownNCT01795768Phase 2
• The Use of a Quality of Life Questionnaire in Patients With Lung CancerStatus unknownNCT01213745Not applicable
• Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung CancerStatus unknownNCT01003522Phase 3
• Diagnosis and Treatment Planning in Patients Suspected of Having Lung CancerStatus unknownNCT00005071Not applicable